Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The effect of MS on endothelial cell prostaglandin (PG) production and cyclooxygenase (COX) mRNA expression was examined in cultured brain endothelial cells from newborn pig cerebral microvessels; grown to confluence and treated with MS (100 ng/ml media) or naloxone (100 ng/ml media). The control cells were treated with an equivalent volume of saline. The cells were exposed to drug or saline for 0 to 96 hours. At the end of each experimental time (n=6 flasks), media was analyzed for PG levels by enzyme immunoassay. The cells were examined for COX-1 and COX-2 mRNA expression by reverse transcriptase-polymerase chain reaction (RT-PCR). MS exposure resulted in significant elevations in vasodilator PG levels (table).
MS had no effect on PGF2α or thromboxane B2. No differences in PG levels were detected between naloxone-treated and control groups. In the morphine-treated cells, COX-1 mRNA was significantly more expressed at 24 hr (40%, p<0.05) to 96 hr (59%,p<0.05). However, COX-2 expression was significantly lower at 24 hr (68%, p<0.05), 48 hr (52%, p<0.05), and 96 hr(39%, p<0.05) compared to the control group. We conclude that MS increases vasodilator prostaglandins in brain endothelial cells. The vasodilator responses to MS may be mediated in part through this mechanism.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com